Comparison of naveibine and cisplatin versus gemcitabine and cisplatin in refractory metastatic breast cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6)1999.
Article
in Chinese
| WPRIM
| ID: wpr-676401
ABSTRACT
0.05).The degreeⅢ～Ⅳthrombocytopenia was more common in group A than in group B,but the degreeⅢ～Ⅳhypolekocytosis and phlebitis was more serious in group B.Conclusion NC and GC for treating refractory metastatic breast cancer have a high response rate and tolerable side effects.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Cancer Research and Clinic
Year:
1999
Type:
Article
Similar
MEDLINE
...
LILACS
LIS